YorkBridge Wealth Partners’s Corcept Therapeutics CORT Stock Holding History

YorkBridge Wealth Partners’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-643	Closed	-$9K	–	754
2018 Q4	$9K	Sell	643 -695	-52%	-$9.19K	﹤0.01%	583
2018 Q3	$18K	Buy	1,338 +22	+2%	+$307	0.01%	539
2018 Q2	$21K	Buy	1,316 +296	+29%	+$5.15K	0.01%	525
2018 Q1	$17K	Buy	1,020 +158	+18%	+$2.93K	0.01%	561
2017 Q4	$15K	Buy	+862	New	+$15.6K	0.01%	590

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

YorkBridge Wealth Partners's CORT Position: Q1 2019 in Review

YorkBridge Wealth Partners sold out of Corcept Therapeutics (CORT) in Q1 2019, closing a stake of 643 shares — an estimated $9K sold.

YorkBridge Wealth Partners first reported a position in CORT in Q4 2017 and held it in 5 quarters. The position peaked at $21K in Q2 2018. 208 funds tracked by Wall St. Rank hold CORT as of Q1 2019.

YorkBridge Wealth Partners reported no remaining Corcept Therapeutics position as of Q1 2019 after selling out during the quarter.
YorkBridge Wealth Partners sold 643 Corcept Therapeutics shares in Q1 2019, an estimated $9K.
YorkBridge Wealth Partners first reported a position in Corcept Therapeutics in Q4 2017 and held it in 5 quarters.
YorkBridge Wealth Partners's Corcept Therapeutics position peaked at $21K in Q2 2018.
208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q1 2019, filed 9 May 2019.